Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Boehringer to move psoriasis programme into phase III

Candidate outperformed J&J’s rival Stelara 

Eli Lilly HQ

Lilly signs cancer pact with Chinese biotech

Marks first major deal between a Western pharma company and a Chinese biotech

- PMLiVE

MHP Health strengthens team with four hires

Kate Pogson joins firm as its new director and joins three further appointments

- PMLiVE

Neurodegenerative research needs better cooperation, say GlobalData

And public funding must be provided to eradicate business risks

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

Actavis makes two additions to board of directors

Michael R Gallagher and Peter J McDonnell join

Understanding the ‘adoption ladder’ in closed loop marketing

Did you know that the very barriers to your product can be turned around to drive its success? Learn the judo strategy that is at the heart of great e-detailing.

Anthill Agency

Sanofi reception

Type 1 diabetes market to double to $13.6bn

New treatments will see this growth by 2023, according to GlobalData

- PMLiVE

FDA panel backs GSK’s asthma drug Breo for adults only

Already approved to treat COPD in the US

Zealand announces management changes

Firm making the roles of chief scientific officer and chief operating officer redundant

- PMLiVE

AZ and Daiichi Sankyo sign Movantik marketing deal

Two firms have agreed the deal for the new constipation pill

Eli Lilly HQ

Lilly inks $690m deal with Hanmi for autoimmune drug

Lilly to pay $50m upfront for rights to HM71224

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links